Welcome to our dedicated page for 3D Systems news (Ticker: DDD), a resource for investors and traders seeking the latest updates and insights on 3D Systems stock.
3D Systems Corp (symbol: DDD) is a pioneer in the 3D printing industry, offering a broad array of 3D printing and digital manufacturing solutions. The company's product portfolio includes 3D printers for plastics and metals, materials, software, on-demand manufacturing services, and digital design tools. With over 35 years of experience, 3D Systems is at the forefront of innovation in additive manufacturing, impacting a wide range of industries from healthcare and dental to aerospace, automotive, and durable goods.
3D Systems' operations are segmented into Healthcare Solutions and Industrial Solutions, with a significant portion of its revenue generated from the Industrial segment. The company has a strong global presence with offices and facilities across the Americas, EMEA, and APAC regions, although the majority of its revenue comes from the Americas.
The company's recent projects have showcased its advanced capabilities in both industrial and healthcare applications. For instance, 3D Systems has pioneered a first-to-market solution for jetted, monolithic dentures, combining bespoke materials to deliver high-performance dental prosthetics. This innovation has gained interest from leading dental labs and is expected to receive FDA clearance in the second half of 2024.
On the industrial front, 3D Systems continues to expand its portfolio. Recently, the company has seen growth in its metal 3D printing division with Wilting, an industrial machining and metal 3D printing service provider, adding multiple DMP Flex 350 metal 3D printers to its production line. This expansion will enable Wilting to meet increasing customer demand more efficiently.
Financially, 3D Systems has been proactive in managing its liabilities and maintaining a strong balance sheet. The company recently entered into repurchase agreements to buy back $110 million of its 0% Convertible Senior Notes due 2026, thereby reducing its outstanding debt significantly.
3D Systems' commitment to innovation is further exemplified by its developments in patient-specific medical devices. The FDA recently cleared its VSP® PEEK Cranial Implant solution, designed for use in cranioplasty procedures, which utilizes additive manufacturing to produce highly customized, cost-effective cranial implants.
Looking ahead, 3D Systems aims to harness its leadership in digital dentistry, with plans to expand its product offerings to include night guards and direct-printed clear aligners. The company has also secured a multi-year purchase agreement, valued at nearly a quarter-billion dollars, to support the indirect manufacturing process for clear aligners, a testament to its robust 3D printing technology and market leadership.
3D Systems' unique combination of hardware, software, materials, and services, powered by expert application engineers, ensures they continue to transform industries and empower their customers to innovate. More information on 3D Systems is available at www.3dsystems.com.
3D Systems (NYSE:DDD) announced the appointment of Michael Turner as Executive Vice President and Chief Financial Officer, effective August 29, 2022. Turner, who brings over 20 years of financial expertise, previously served as CFO at Innovative Chemical Products and held various finance leadership roles at Albemarle Corporation. His experience includes driving financial controls and implementing technology-based strategies. CEO Dr. Jeffrey Graves expressed enthusiasm for Turner's impact on the company's growth trajectory. Wayne Pensky is recognized for his interim leadership during the transition.
3D Systems has collaborated with Fleet Space Technologies to develop RF patch antennas for their Alpha satellite constellation. Utilizing the DMP Flex 350 printer, Fleet Space will produce antennas in-house, significantly enhancing production efficiency. The development process, requiring only three weeks for small batch production, leverages advanced additive manufacturing techniques. This partnership aims to improve global connectivity and support sustainable mineral exploration. The DMP Flex 350 allows for precise manufacturing, reducing signal loss and operational costs.
3D Systems (NYSE:DDD) will announce its second quarter 2022 financial results on August 8, 2022, after U.S. market close. The company has scheduled a conference call and webcast for August 9, 2022, at 8:30 a.m. ET to discuss these results. Investors can access the webcast at 3D Systems Investor Relations. This event marks an important opportunity for stakeholders to gain insights into the company's performance and outlook.
3D Systems and EMS-GRILTECH have launched DuraForm® PAx Natural, a pioneering nylon copolymer for Selective Laser Sintering (SLS) platforms. Designed for high-impact and elongation applications, it operates at low temperatures (120°C), enhancing printing efficiency and reducing time to delivery. As the exclusive distributor, 3D Systems reports that this eco-friendly material can increase production throughput and minimize waste, featuring over five years of indoor stability. Early adopters commend its performance, highlighting a shift in the cost structure for SLS technology.
3D Systems has appointed Dr. David J. Shulkin, former U.S. Secretary of Veterans Affairs, to its newly formed Medical Advisory Board. The board's mission is to enhance the company's initiatives in regenerative medicine. Dr. Shulkin, noted for his leadership in healthcare management, aims to guide 3D Systems in expanding its Healthcare Solutions business, primarily focusing on dental and orthopedic applications. His experience in patient-centered care is expected to bolster the company's strategic direction in applying 3D printing technologies in medicine.
United Therapeutics and 3D Systems Corporation have unveiled the world's most complex 3D-printed object – a human lung scaffold – at the LIFE ITSELF Conference in San Diego. The scaffolds, demonstrating gas exchange in animal models, consist of 44 trillion voxels with extensive pulmonary structures and are expected to enter human clinical trials within five years. Additionally, current methods extend the viability of human donor lungs, enhancing transplant availability. This initiative aligns with United Therapeutics’ goal to create an unlimited supply of transplantable organs.
3D Systems (NYSE: DDD) has announced that its management will present at the Stifel 2022 Cross Sector Insight Conference in Boston, MA on June 8 at 3:35 p.m. Eastern Time. A live webcast of the presentation will be accessible on the Events and Presentations section of 3D Systems’ website and will remain available for replay for at least 30 days following the event. This presentation aims to provide insights into the company's advancements in Additive Manufacturing solutions across various industries.
3D Systems (NYSE:DDD) has established its inaugural Medical Advisory Board (MAB), appointing Stephen K. Klasko, MD, MBA, as Chair. The MAB aims to provide strategic guidance for the company's regenerative medicine initiatives as they transition to advanced development and human application. Dr. Klasko, noted for his transformative leadership at Jefferson Health—growing its revenue from $1 billion to over $9 billion—will leverage his expertise to mitigate risks and enhance program objectives. His vision focuses on integrating digital technology with healthcare to improve outcomes and reduce costs.
3D Systems has partnered with Airbus Defence and Space to produce components for OneSat, the first satellite that can be fully reconfigured in orbit. This multi-year contract includes the development of antennae for the entire OneSat fleet. Utilizing their DMP Factory 500 Solution, 3D Systems will manufacture two large antenna arrays per satellite, optimizing performance and reducing weight. This collaboration showcases 3D Systems' extensive expertise in additive manufacturing, which has been honed through successful past projects with Airbus, enhancing supply chain efficiency in the aerospace sector.
3D Systems Corporation (NYSE:DDD) reported Q1 2022 revenue of $133.0 million, a 9.0% decline year-over-year, driven by asset divestitures. Adjusted for these divestitures, revenue increased by 10%. The company experienced an adjusted EBITDA margin of 1.4% and a diluted GAAP loss per share of $0.21. Cash and short-term investments stood at $745.6 million. Despite challenges like supply chain issues and geopolitical tensions, strong demand was noted in the Industrial and Healthcare segments, with adjusted year-over-year revenue growth of 15.7% and 4.6%, respectively.
FAQ
What is the current stock price of 3D Systems (DDD)?
What is the market cap of 3D Systems (DDD)?
What does 3D Systems Corp do?
What are the main segments of 3D Systems' business?
What recent innovations has 3D Systems introduced?
How is 3D Systems expanding its digital dentistry portfolio?
What is the significance of 3D Systems' recent debt repurchase?
How does 3D Systems impact the healthcare industry?
What are some of the industries served by 3D Systems?
Where does 3D Systems generate most of its revenue?
What is 3D Systems' approach to supporting customer demand?
How long has 3D Systems been in the 3D printing industry?
